Chat with us, powered by LiveChat

Tag: endonuclease

Trials in gene editing in humans about to begin in 2017

The biotechnology company Editas hopes to begin clinical trials using the latest gene editing technique on human subjects in 2017, according to the company’s CEO Katrine Bosley. The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as plasmids and phages, and provides a form of acquired immunity.

Continue reading